Endra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com) News

8-K: Current report

Nov 5 21:01

8-K: Current report

Oct 30 04:11

DEFA14A: Others

Sep 18 00:32

DEF 14A: Definitive information statements

Sep 17 05:32

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 7 04:35

8-K: Current report

Aug 29 05:13

8-K: ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 24 04:07

8-K: Current report

Aug 17 04:14

8-K: Current report

Aug 13 21:27

8-K: Current report

Aug 9 20:07

DEFA14A: Others

Jul 18 04:22

8-K: Current report

Jul 18 04:22

DEF 14A: Definitive information statements

Jun 26 04:21

DEFA14A: Others

Jun 26 04:12

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jun 13 05:27

8-K: Current report

Jun 6 20:01

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jun 1 04:24

8-K: Current report

May 20 20:10

8-K: ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 15 04:24

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 11 05:20